Qiagen has launched QIAstat-Dx Rise, a high-capacity version of the QIAstat-Dx automated syndromic system. The company has also released enhancements to its QIAstat-Dx menu of tests.
QIAstat-Dx Rise is compatible with Qiagen's updated QIAstat-Dx respiratory SARS-CoV-2 panel, the QIAstat-Dx gastrointestinal panel 2, as well as future assays. It provides results in about one hour.
QIAstat-Dx Rise and its test cartridges constitute a closed system for hands-off sample preparation and processing. With a random-access capacity of up to 18 different tests, it can provide diagnostic results for up to 56 tests in an eight-hour shift and 160 tests per day by using eight analytical modules.
Other developments in the QIAstat-Dx portfolio include the following:
- QIAstat-Dx respiratory SARS-CoV-2 Panel has been expanded to also test for Chlamydophila pneumoniae, and this panel can be used to detect and differentiate among 23 viral and bacterial targets that cause respiratory infections
- QIAstat-Dx gastrointestinal panel 2 has been updated and can be used to detect and differentiate among 22 viral, bacterial, and parasitic targets that cause gastrointestinal infections; the panel's STEC target (Shiga-like toxin E. coli) reports the toxin content
- Software for QIAstat-Dx Analyzer has been updated to enhance the system's cybersecurity, usability, and connectivity features
